Inventor · disambiguated record
Timothy J. Hartingh
Also filed as: HARTINGH TIMOTHY J · HARTINGH TIMOTHY JOHN
14 granted patents·4 pending applications·38 citations·filing 2009–2023
88Inventor score
Files withMERCK SHARP & DOHME12MERCK SHARP & DOHME LLC2BRESLIN MICHAEL J1CONVERSO ANTONELLA1GARBACCIO ROBERT M1
Top patents by PatentIndex Score
18 records- 0195US9822138B2Antiviral beta-amino acid ester phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2016·Granted Nov 21, 2017·12 cites·81 claims
- 0282US8975261B2Aryloxmethyl cyclopropane derivatives as PDE10 inhibitorsBRESLIN MICHAEL J·Filed 2012·Granted Mar 10, 2015·4 cites·13 claims
- 0381US9643982B2Fused tricyclic heterocyclic compounds as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 9, 2017·3 cites·14 claims
- 0481US9278960B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2012·Granted Mar 8, 2016·4 cites·21 claims
- 0578US8329697B2Imidizo[1,2-A]pyrazines useful as AHCY hydrolase inhibitorsGARBACCIO ROBERT M·Filed 2009·Granted Dec 11, 2012·7 cites·7 claims
- 0676US10745428B2Antiviral phosphodiamide prodrugs of tenofovirMERCK SHARP & DOHME·Filed 2016·Granted Aug 18, 2020·1 cites·4 claims
- 0776US9663506B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 0876US9636337B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 2, 2017·2 cites·30 claims
- 0971US8629275B2AHCY hydrolase inhibitors for treatment of hyper homocysteinemiaCONVERSO ANTONELLA·Filed 2009·Granted Jan 14, 2014·3 cites·16 claims
- 1062US11958864B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Apr 16, 2024·0 cites·19 claims
- 1159US2025223259A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1254US11413292B2Tricyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Aug 16, 2022·0 cites·18 claims
- 1350US2015218164A1Substituted naphthyridinedione derivatives as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 1448US2018065999A1Antiviral beta-amino acid ester phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1545US11123355B2Antiviral benzyl-amine phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2017·Granted Sep 21, 2021·0 cites·20 claims
- 1645US2011178117A1Oxazolobenzimidazole derivativesMERCK SHARP & DOHME·Filed 2009·Application pending·0 cites
- 1740US10736908B2Antiviral aryl-amide phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2017·Granted Aug 11, 2020·0 cites·14 claims
- 1834US9108937B2Positive allosteric modulators of mGluR2LAYTON MARK E·Filed 2011·Granted Aug 18, 2015·0 cites·26 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →